Back to News
Market Impact: 0.1
Artemis Growth Partners Appoints James Hayward as Advisory Director Amid Institutional Shift in Global Emergent Medicinal Therapeutics
Source: PR Newswire
Management & GovernancePrivate Markets & VentureHealthcare & Biotech
Artemis Growth Partners, an investment firm focused on regulated medical cannabis and emerging medicinal therapeutics, appointed James Hayward as Advisory Director. The announcement is a governance and advisory-team update, with no financial terms, investment figures, or operating targets disclosed in the provided text.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Street Calls of The Week
- Binance CFO exits days after catastrophic $6 billion crypto hack
- Coffee giant Dutch Bros made all of its executives, including the CEO, do a two-week bootcamp where they learned how to pour drinks and run stores
- Binance CFO is leaving to ‘pursue a new venture’ after $6.3 billion hack
- Poland’s Domanski blames presidential vetoes as S&P cuts outlook to negative
- Berkshire Makes Record $9.6 Billion Buyback